01 5Madopar
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 378
2018 Revenue in Millions : 351
Growth (%) : 8
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 402
2019 Revenue in Millions : 409
Growth (%) : -2
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 424
2020 Revenue in Millions : 383
Growth (%) : 9
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 414
2021 Revenue in Millions : 424
Growth (%) : -2
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 412
2022 Revenue in Millions : 414
Growth (%) : -6
